Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Alexion Pharmaceuticals Tops Expectations in Q2

TheMotleyFool

0 0

Alexion Pharmaceuticals Tops Expectations in Q2Photo, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Alexion Pharmaceuticals (NASDAQ: ALXN) gave investors a lot to like when it announced its first-quarter results in April. Revenue increased by 23% year over year, while adjusted earnings were up by 42%.

The biotech announced its second-quarter results before the market opened on Wednesday. And Alexion again provided plenty of reasons for investors to be happy. Here are the highlights from the company's Q2 update.

Image source: Getty Images.

Quelle Fool.com

Like: 0

ALXN

Teilen